Everest Re Group, Ltd. (EG) 10-Year Financial Performance & Capital Metrics

EG • • Insurance & Managed Care

Financial ServicesReinsuranceHybrid Reinsurance/InsuranceIntegrated Reinsurance & Insurance Providers

AboutEverest Group, Ltd., through its subsidiaries, provides reinsurance and insurance products in the United States, Bermuda, and internationally. The company operates through Reinsurance Operations and Insurance Operations segments. The Reinsurance Operations segment writes property and casualty reinsurance; and specialty lines of business through reinsurance brokers, as well as directly with ceding companies in the United States, Bermuda, Ireland, Canada, Singapore, Switzerland, and the United Kingdom. The Insurance Operations segment writes property and casualty insurance directly, as well as through brokers, surplus lines brokers, and general agents in the United States, Bermuda, Canada, Europe, South America, France, Germany, Spain, Canada, Chile, the United Kingdom, Ireland, and the Netherlands. The company also provides treaty and facultative reinsurance products; admitted and non-admitted insurance products; and property and casualty reinsurance and insurance coverages, including marine, aviation, surety, errors and omissions liability, directors' and officers' liability, medical malpractice, mortgage reinsurance, other specialty lines, accident and health, and workers' compensation products. In addition, it offers commercial property and casualty insurance products through wholesale and retail brokers, surplus lines brokers, and program administrators. The company was formerly known as Everest Re Group, Ltd. and changed its name to Everest Group, Ltd. in July 2023. The company was founded in 1973 and is headquartered in Hamilton, Bermuda.Show more

Revenue $17.08B +18.1%
Combined Ratio 91.25% +7.2%
Net Income $1.37B -45.5%
Return on Equity 10.14% -56.4%
Medical Cost Ratio 85.53% +8.7%
Operating Margin 8.75% -41.2%
Net Margin 8.04% -53.8%
ROA 2.6% -53.9%
Equity / Assets 24.63% -7.8%
Book Value per Share 324.96 +1.7%
Tangible BV/Share 324.96 +1.7%
Debt/Equity 0.43 -1.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Profitable underwriting: 91.2% combined ratio
✓12 consecutive years of dividend growth
✓Healthy dividend yield of 2.4%
✓Trading at only 1.0x book value

✗Weaknesses

✗High loss ratio of 85.5%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y11.64%

5Y15.71%

3Y14.66%

TTM8.85%

Profit (Net Income) CAGR

10Y1.36%

5Y6.34%

3Y-0.15%

TTM-80.07%

EPS CAGR

10Y2.06%

5Y5.17%

3Y-2.81%

TTM-79.45%

ROCE

10Y Avg4.7%

5Y Avg3.12%

3Y Avg3.09%

Latest2.83%

Peer Comparison

Integrated Reinsurance & Insurance Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SPNTSiriusPoint Ltd.	2.38B	20.40	19.62	-3.28%	6.98%	8.97%	3.13%	0.33
EGEverest Re Group, Ltd.	13.48B	321.21	10.11	18.06%	3.15%	3.59%	36.76%	0.43
HGHamilton Insurance Group, Ltd.	1.7B	26.37	7.19	47.03%	15.65%	15.98%	44.62%	0.06

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	5.68B	5.79B	6.62B	7.36B	8.23B	9.6B	11.33B	11.98B	14.46B	17.08B
Revenue Growth %	-0%	0.02%	0.14%	0.11%	0.12%	0.17%	0.18%	0.06%	0.21%	0.18%
Medical Costs & Claims+	4.25B	4.33B	5.83B	7.17B	6.63B	8.42B	9.6B	10.63B	11.38B	14.61B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	1.43B	1.47B	795.75M	191.06M	1.6B	1.17B	1.73B	1.36B	3.08B	2.47B
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-0.15%	0.03%	-0.46%	-0.76%	7.4%	-0.27%	0.47%	-0.21%	1.27%	-0.2%
Operating Expenses+	316.51M	366.18M	376.34M	433.24M	505.56M	588M	184M	769M	931M	976M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	1.11B	1.1B	419.41M	-242.18M	1.1B	586M	1.54B	588M	2.15B	1.5B
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.2%	-0.01%	-0.62%	-1.58%	5.54%	-0.47%	1.63%	-0.62%	2.66%	-0.31%
EBITDA+	1.15B	1.14B	451.01M	-211.15M	1.13B	621M	1.62B	689M	2.29B	1.64B
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	36.19M	36.23M	31.6M	31.03M	31.69M	36M	70M	101M	134M	149M
Non-Operating Income	-36.19M	-36.23M	-31.6M	-31.03M	-31.69M	-35M	-72M	-101M	-134M	-147M
Pretax Income+	1.11B	1.1B	419.41M	-242.18M	1.1B	585M	1.55B	588M	2.15B	1.49B
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	134.02M	103.5M	-63.34M	-331.22M	89.53M	71M	167M	-9M	-363M	120M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	977.87M	996.34M	482.75M	89.04M	1.01B	514M	1.38B	597M	2.52B	1.37B
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.18%	0.02%	-0.52%	-0.82%	10.34%	-0.49%	1.68%	-0.57%	3.22%	-0.45%
EPS (Diluted)+	22.10	23.68	11.36	2.53	24.70	12.78	34.62	15.10	60.24	31.78
EPS Growth %	-0.15%	0.07%	-0.52%	-0.78%	8.76%	-0.48%	1.71%	-0.56%	2.99%	-0.47%
EPS (Basic)	22.29	23.85	11.43	2.54	24.77	12.81	34.66	15.10	60.19	31.78
Diluted Shares Outstanding	44.25M	42.08M	41.28M	40.93M	40.42M	39.73M	39.3M	39M	41.3M	42.7M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	21.43B	21.32B	23.59B	24.79B	27.32B	32.71B	38.19B	39.97B	49.4B	56.34B
Asset Growth %	0.03%	-0%	0.11%	0.05%	0.1%	0.2%	0.17%	0.05%	0.24%	0.14%
Total Investment Assets+	16.39B	17B	17.99B	17.78B	19.94B	24.66B	28.23B	28.47B	35.7B	39.98B
Long-Term Investments	16.6B	15.67B	16.36B	16.19B	18.18B	22.65B	25.31B	24.39B	30.91B	34.59B
Short-Term Investments	16.6B	15.67B	16.36B	15.47B	5.82B	8.34B	23.49B	23.27B	15.14B	18.89B
Total Current Assets+	17.67M	17.48M	18.63M	18.43M	0	0	0	30.98B	0	0
Cash & Equivalents	283.66M	481.92M	635.07M	656.1M	808.04M	801.65M	1.44B	1.4B	1.44B	1.55B
Receivables	0	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	-11.41B	-14.24B	-30.79B	2.18B	-25.19B	-31.03B
Goodwill & Intangibles+	372.35M	344.05M	411.59M	511.57M	0	0	0	962M	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	372.35M	344.05M	411.59M	511.57M	0	0	0	962M	0	0
PP&E (Net)	0	0	0	0	0	0	0	128M	0	0
Other Assets	2.69B	3.34B	4.34B	5.22B	-18.18B	-22.65B	-25.31B	-128M	-30.91B	-34.59B
Total Liabilities	12.94B	13.25B	15.22B	16.89B	18.19B	22.99B	28.05B	31.52B	36.2B	42.47B
Total Debt+	632.96M	633.18M	633.39M	633.61M	1.03B	3.29B	5.43B	5.43B	5.74B	5.94B
Net Debt	349.3M	151.25M	-1.67M	-22.48M	222.87M	2.49B	3.99B	4.03B	4.3B	4.39B
Long-Term Debt	636.5M	633.18M	633.39M	236.66M	633.83M	1.91B	3.09B	737M	3.39B	3.59B
Short-Term Debt	0	0	0	0	397.07M	1.38B	2.35B	2.35B	2.35B	2.35B
Total Current Liabilities+	12.3B	12.61B	14.59B	16.26B	0	0	0	2.91B	0	0
Accounts Payable	173.09M	190.99M	218.02M	218.44M	291.66M	294.35M	450M	567M	650M	701M
Deferred Revenue	1.61B	1.58B	2B	2.52B	0	0	0	0	0	0
Other Current Liabilities	12.11B	12.39B	14.33B	15.98B	-722.26M	-1.89B	-2.83B	-2.93B	-3.16B	-3.16B
Deferred Taxes	1000K	1000K	1000K	1000K	0	0	0	0	0	0
Other Liabilities	-636.5M	12.54B	14.58B	16.64B	-633.83M	-1.91B	-3.09B	-737M	-3.39B	-3.59B
Total Equity+	7.61B	8.08B	8.37B	7.86B	9.13B	9.73B	10.14B	8.44B	13.2B	13.88B
Equity Growth %	0.02%	0.06%	0.04%	-0.06%	0.16%	0.06%	0.04%	-0.17%	0.56%	0.05%
Shareholders Equity	7.61B	8.08B	8.37B	7.86B	9.13B	9.73B	10.14B	8.44B	13.2B	13.88B
Minority Interest	0	0	0	0	0	0	0	0	0	0
Retained Earnings	8.62B	9.42B	9.68B	9.57B	10.31B	10.57B	11.7B	12.04B	14.27B	15.31B
Common Stock	686K	689K	691K	692K	694K	696K	1M	1M	1M	1M
Accumulated OCI	-231.75M	-216.76M	-160.89M	-462.56M	28.15M	534.9M	12M	-2B	-934M	-1.14B
Return on Equity (ROE)	0.13%	0.13%	0.06%	0.01%	0.12%	0.05%	0.14%	0.06%	0.23%	0.1%
Return on Assets (ROA)	0.05%	0.05%	0.02%	0%	0.04%	0.02%	0.04%	0.02%	0.06%	0.03%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.08x	0.08x	0.08x	0.08x	0.11x	0.34x	0.54x	0.64x	0.43x	0.43x
Book Value per Share	171.96	191.93	202.73	192.06	225.95	244.78	257.99	216.44	319.66	324.96
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.11B	1.38B	1.16B	610.07M	1.85B	2.87B	3.83B	3.69B	4.55B	4.96B
Operating CF Growth %	0.05%	0.25%	-0.16%	-0.48%	2.04%	0.55%	0.33%	-0.04%	0.23%	0.09%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	977.87M	996.34M	482.75M	89.04M	1.01B	514M	1.38B	597M	2.52B	1.37B
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0
Stock-Based Compensation	21.24M	26.4M	30.3M	32.37M	34.02M	39M	43M	45M	49M	63M
Deferred Taxes	-96.62M	0	0	-14.51M	0	0	0	0	0	0
Other Non-Cash Items	289.03M	118.39M	-56.5M	241.03M	-72.77M	-95M	30M	689M	332M	-22M
Working Capital Changes	-179.9M	242.47M	706.15M	247.63M	881.29M	2.42B	2.38B	2.36B	1.66B	3.54B
Cash from Investing+	-681.1M	-657.87M	-732.58M	-279.62M	-1.41B	-3.68B	-3.87B	-3.42B	-5.9B	-4.48B
Capital Expenditures	57.2M	4.82B	0	0	0	0	0	0	0	0
Acquisitions	3.93M	47.72M	0	0	0	0	0	0	0	0
Purchase of Investments	-5.29B	-4.43B	-5.67B	-7.22B	-7.11B	-8.54B	-9.97B	-8.5B	-11.82B	-14.16B
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	-252.12M	-563.13M	-280.46M	-222.39M	-167.04M	-52M	-702M	-1.35B	-476M	-556M
Cash from Financing+	-332.88M	-570.92M	-275.46M	-316.59M	-275.69M	800M	674.19M	-359M	1.41B	-383M
Dividends Paid	-175.11M	-195.38M	-207.24M	-216.22M	-234.32M	-249M	-247M	-255M	-288M	-334M
Share Repurchases	-400.06M	-386.29M	-50M	-75.3M	-24.6M	-200M	-225M	-61M	0	-200M
Stock Issued	13.6M	10.75M	0	0	0	0	0	0	1.45B	0
Debt Issuance (Net)	0	0	0	0	0	1000K	1000K	0	1000K	1000K
Other Financing	2M	156K	-18.22M	-25.07M	-16.76M	-40M	-31M	-43M	-48M	-49M
Net Change in Cash+	-153.82M	198.26M	153.15M	21.03M	151.94M	-6M	639.21M	-43M	39M	112M
Exchange Rate Effect	-1000K	1000K	-1000K	1000K	-1000K	1000K	639K	1000K	-1000K	1000K
Cash at Beginning	437.47M	283.66M	481.92M	635.07M	656.1M	808.04M	801.65M	1.44B	1.4B	1.44B
Cash at End	283.66M	481.92M	635.07M	656.1M	808.04M	801.65M	1.44B	1.4B	1.44B	1.55B
Free Cash Flow+	1.11B	1.38B	1.16B	610.07M	1.85B	2.87B	3.83B	3.69B	4.55B	4.96B
FCF Growth %	0.05%	0.25%	-0.16%	-0.48%	2.04%	0.55%	0.33%	-0.04%	0.23%	0.09%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	25.05	32.88	28.16	14.91	45.82	72.33	97.52	94.74	110.24	116.09

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	80.41%	81.02%	93.67%	103.29%	86.65%	93.89%	86.37%	95.09%	85.11%	91.25%
Medical Cost Ratio	74.84%	74.7%	87.98%	97.4%	80.51%	87.77%	84.75%	88.68%	78.67%	85.53%
Return on Equity (ROE)	12.99%	12.71%	5.87%	1.1%	11.88%	5.45%	13.88%	6.43%	23.26%	10.14%
Return on Assets (ROA)	4.63%	4.66%	2.15%	0.37%	3.87%	1.71%	3.89%	1.53%	5.63%	2.6%
Equity / Assets	35.51%	37.87%	35.48%	31.7%	33.42%	29.73%	26.55%	21.12%	26.73%	24.63%
Book Value / Share	171.96	191.93	202.73	192.06	225.95	244.78	257.99	216.44	319.66	324.96
Debt / Equity	0.08x	0.08x	0.08x	0.08x	0.11x	0.34x	0.54x	0.64x	0.43x	0.43x
Revenue Growth	-0.04%	2.07%	14.29%	11.16%	11.81%	16.61%	18.02%	5.8%	20.68%	18.06%

Revenue by Segment

	2024
Reinsurance	11.41B
Reinsurance Growth	-
Insurance	3.58B
Insurance Growth	-
Other Operating	197M
Other Operating Growth	-

Frequently Asked Questions

Valuation & Price

Everest Re Group, Ltd. (EG) has a price-to-earnings (P/E) ratio of 10.1x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Everest Re Group, Ltd. (EG) grew revenue by 18.1% over the past year. This is strong growth.

Yes, Everest Re Group, Ltd. (EG) is profitable, generating $552.0M in net income for fiscal year 2024 (8.0% net margin).

Dividend & Returns

Yes, Everest Re Group, Ltd. (EG) pays a dividend with a yield of 2.44%. This makes it attractive for income-focused investors.

Everest Re Group, Ltd. (EG) has a return on equity (ROE) of 10.1%. This is reasonable for most industries.

Industry Metrics

Everest Re Group, Ltd. (EG) has a combined ratio of 91.2%. A ratio below 100% indicates underwriting profitability.

US Stock Screener

...